Skip to main content

Base Genomics is a new start-up that aims to have a major impact on personalised medicine. We are developing TAPS, a breakthrough technology from the University of Oxford that makes epigenetic analysis of DNA methylation more sensitive, accurate and cheaper than ever before. We aim to transform healthcare by enabling early and precise detection of cancer. Long-term, we expect TAPS to become central to a host of major new healthcare and research applications